GlassScriptPhysician profile
Roberto C Bergamaschi
NPI 1497755318
$283,287.69
in general payments reported to CMS, 2019-2025
20 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,588 · 2020: $102K · 2021: $127K · 2022: $960 · 2023: $50K · 2024: $999 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50K · Food and Beverage: $2,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49,640.00 |
| Food and Beverage | $2,034.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thd America, INC. | $276,879.10 | 2020-2023 | |
| Dilon Technologies, INC. | $1,648.19 | 2022-2025 | Hemoblast Bellows |
| Allergan, INC. | $1,489.34 | 2019-2022 | |
| Integra Lifesciences Corporation | $849.54 | 2020-2022 | |
| Biom'Up France Sas | $741.51 | 2020-2021 | |
| Tei Biosciences INC | $380.66 | 2019 | |
| Abbvie INC. | $359.25 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Acell, INC. | $215.94 | 2019 | |
| Biom'Up Sa | $131.76 | 2019 | |
| Ethicon US, LLC | $121.00 | 2019 | |
| Activ Surgical, INC. | $118.51 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.24 | 2021 | |
| Kerecis Limited | $85.76 | 2022 | |
| Intuitive Surgical, INC. | $45.34 | 2019 | |
| Covidien LP | $35.75 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $25.44 | 2019 | |
| Teleflex LLC | $21.03 | 2022 | |
| Davol INC. | $20.36 | 2023 | Phasix Mesh |
| Heron Therapeutics, INC. | $19.87 | 2021 | |
| Coloplast Corp | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Bergamaschi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.